Yerevan /Mediamax/. The combination of the first component of Russian Sputnik V vaccine with the U.S. Moderna vaccine has shown high immune response.
TASS reports that the data of the study carried out in Argentine with the support of the Russian Direct Investment Fund has confirmed it.
The combination of the Russian vaccine and AstraZeneca has not shown significant changes in immunogenicity.
The results of the study of combination of Sputnik V and Chinese Sinopharm vaccines are still being analyzed.
Comments
Dear visitors, You can place your opinion on the material using your Facebook account. Please, be polite and follow our simple rules: you are not allowed to make off - topic comments, place advertisements, use abusive and filthy language. The editorial staff reserves the right to moderate and delete comments in case of breach of the rules.